Doctoral thesis
OA Policy
English

Genomic profiling of Anaplastic Large Cell Lymphoma

Contributors

Boi, Michela

Defense date

2013-07-29

Abstract

ALCL is one of the most common form of NHL. ALCL has been separated in two distinct entities based on the presence or absence of translocations affecting ALK gene. The aim of this project is to demonstrate that ALK+ and ALK- subsets can definitively be considered different entities. ALK- ALCL samples have a more perturbated and complex profile. Among all the ALCLs, the most common losses affected 17p13.3-p12 (TP53, 25%) and 6q21 (PRDM1, 19%). PRDM1 was inactivated in 12/31 (39%) and in 1/33 (3%) of clinical specimens derived from ALK- and ALK+ ALCL respectively, in 4/7 (57%) ALCL cell lines. We perform gain-of-function experiments in order to unravel the function of BLIMP1 loss in ALCL pathogenesis. After the re-expression of PRDM1, ALCL cells underwent proliferation arrest, with a concomitant moderate increase in the percentage of apoptotic cells and an arrest in cell cycle, suggesting a tumor suppressor role for BLIMP1.

Keywords

  • ALCL
  • BLIMP1
  • TP53
  • Genomic
  • SNP

UNIGE affiliation entities

Citation (ISO format)

BOI, Michela. Genomic profiling of Anaplastic Large Cell Lymphoma. Doctoral Thesis, 2013. doi: 10.13097/archive-ouverte/unige:33246

Main files (1)

Thesis

Identifiers

857views
891downloads

Technical informations

Creation

26/09/2013 12:34:00

First validation

26/09/2013 12:34:00

Update

14/03/2023 20:50:55

Status update

14/03/2023 20:50:55

Last indexation

13/05/2025 16:30:27
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated